1. Home
  2. LGND vs PTY Comparison

LGND vs PTY Comparison

Compare LGND & PTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • PTY
  • Stock Information
  • Founded
  • LGND 1987
  • PTY 2002
  • Country
  • LGND United States
  • PTY United States
  • Employees
  • LGND N/A
  • PTY N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • PTY Investment Managers
  • Sector
  • LGND Health Care
  • PTY Finance
  • Exchange
  • LGND Nasdaq
  • PTY Nasdaq
  • Market Cap
  • LGND 2.3B
  • PTY 2.2B
  • IPO Year
  • LGND 1992
  • PTY N/A
  • Fundamental
  • Price
  • LGND $120.43
  • PTY $14.53
  • Analyst Decision
  • LGND Strong Buy
  • PTY
  • Analyst Count
  • LGND 6
  • PTY 0
  • Target Price
  • LGND $145.00
  • PTY N/A
  • AVG Volume (30 Days)
  • LGND 107.6K
  • PTY 550.4K
  • Earning Date
  • LGND 11-07-2024
  • PTY 01-01-0001
  • Dividend Yield
  • LGND N/A
  • PTY 9.65%
  • EPS Growth
  • LGND 160.46
  • PTY N/A
  • EPS
  • LGND 2.47
  • PTY N/A
  • Revenue
  • LGND $152,422,000.00
  • PTY N/A
  • Revenue This Year
  • LGND $26.86
  • PTY N/A
  • Revenue Next Year
  • LGND $13.16
  • PTY N/A
  • P/E Ratio
  • LGND $48.80
  • PTY N/A
  • Revenue Growth
  • LGND N/A
  • PTY N/A
  • 52 Week Low
  • LGND $67.53
  • PTY $11.92
  • 52 Week High
  • LGND $129.90
  • PTY $14.88
  • Technical
  • Relative Strength Index (RSI)
  • LGND 52.94
  • PTY 36.75
  • Support Level
  • LGND $113.39
  • PTY $14.51
  • Resistance Level
  • LGND $124.03
  • PTY $14.85
  • Average True Range (ATR)
  • LGND 5.31
  • PTY 0.07
  • MACD
  • LGND -0.50
  • PTY -0.03
  • Stochastic Oscillator
  • LGND 48.65
  • PTY 17.92

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

Share on Social Networks: